Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)

The Tobacco Regulatory Science Small Grant Program for New Investigators is a federal funding opportunity administered by the National Institutes of Health (NIH) with financial support from the U.S. Food and Drug Administration (FDA) Center for Tobacco Products. This program operates under the authority of the Family Smoking Prevention and Tobacco Control Act, which empowers the FDA to regulate the manufacturing, distribution, and marketing of tobacco products. The initiative is specifically designed to support early-stage investigators who are building independent research careers and have not yet secured major NIH funding. By leveraging a collaborative partnership between NIH and FDA, the program aims to expand the scientific evidence base needed to inform public health protections related to tobacco use. The primary purpose of this funding opportunity is to support small-scale research projects that can be conducted within a short timeframe and with limited resources. The R03 mechanism is intended for pilot studies, feasibility assessments, secondary analyses of existing datasets, methodological development, and exploratory research that may lead to larger future investigations. All funded research must align with FDA regulatory priorities and address at least one designated high-priority research topic. These topics include addiction mechanisms related to nicotine delivery systems, behavioral patterns associated with tobacco product use, health impacts of emerging tobacco products, product composition and design, and toxicity effects. The expectation is that funded projects will produce actionable findings that directly inform FDA regulatory decisions. Funding under this program is relatively modest but strategically targeted. Applicants may request up to seventy-five thousand dollars in direct costs per year for a maximum project period of two years. The total anticipated funding for the program is up to five hundred thousand dollars in a single fiscal year, with approximately four awards expected. Funds are intended to support research activities such as data collection, analysis, and development of new methodologies or technologies. There is no cost-sharing or matching requirement, which lowers barriers to entry for early-career investigators and institutions with limited financial resources. Eligibility for the program is broad in terms of organizational types but narrow in terms of investigator status. Eligible applicants include higher education institutions, nonprofit organizations, for-profit entities, and various levels of government, including tribal governments. However, foreign organizations and non-domestic components are not eligible. The principal investigator must qualify as a new investigator, meaning they have not previously received significant NIH research funding such as an R01 or equivalent awards from FDA tobacco-related programs. This ensures that the funding is directed toward individuals who are in the early stages of establishing independent research careers in tobacco regulatory science. The application process requires submission through federal grant systems such as Grants.gov, NIH ASSIST, or institutional system-to-system solutions. Applicants must complete required registrations, including SAM, eRA Commons, and Grants.gov, prior to submission. Applications must follow the NIH Research Instructions and include standard components such as project narratives, budget justifications, and data management plans. Compliance with formatting and submission requirements is strictly enforced, and noncompliant applications may be rejected without review. Applicants are encouraged to consult program contacts prior to submission to ensure alignment with program priorities. Applications are evaluated through the NIH peer review process based on scientific merit, feasibility, and investigator qualifications. Review criteria include the significance and innovation of the research, the rigor and feasibility of the proposed approach, and the expertise and environment of the research team. Additional considerations include protections for human subjects, data management plans, and overall alignment with FDA regulatory needs. Only the most competitive applications proceed to funding consideration, where final decisions also account for program priorities and available funding. The program operates on a structured timeline with multiple submission cycles. Key application deadlines occur in November 2025 and July 2026, with corresponding review and award timelines extending into 2027. Applications must be submitted by 5:00 PM local time of the applicant organization, and late submissions are not accepted. Awards are typically announced several months after peer review and advisory council evaluation, with project start dates following shortly thereafter. The funding opportunity expires in mid-July 2026 but may be reissued in future cycles, indicating a recurring federal investment in tobacco regulatory science research.

Investigators are strongly encouraged to contact the Scientific/Research Contacts before submitting applications to ensure responsiveness to the NOFO.